Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
45 hedge funds and large institutions have $32.2M invested in Infinity Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 6 closing their positions.
2,600% more call options, than puts
Call options by funds: $81K | Put options by funds: $3K
28% more capital invested
Capital invested by funds: $25.1M → $32.2M (+$7.1M)
3.6% more ownership
Funds ownership: 48.4% → 52% (+3.6%)
6% less funds holding
Funds holding: 48 → 45 (-3)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.26M |
| 2 |
Renaissance Technologies
New York
|
+$161K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$98.5K |
| 4 |
Goldman Sachs
New York
|
+$55.9K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$52.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$614K |
| 2 |
QI
QS Investors
New York
|
-$123K |
| 3 |
AFG
American Financial Group
Cincinnati,
Ohio
|
-$18K |
| 4 |
CB
Community Bank
Dewitt,
New York
|
-$12.3K |
| 5 |
Two Sigma Investments
New York
|
-$12K |
INFI Hedge Fund Activity: Q3 2020 in Review
45 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2020, worth a combined $32.2M — up 28% from $25.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of INFI and 3 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Opaleye Management, opening a new position worth an estimated $3.26M. The largest seller was Dimensional Fund Advisors, cutting an estimated $614K.
- 45 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2020, down from 48 in Q2 2020.
- Funds reported $32.2M of Infinity Pharmaceuticals, Inc. stock for Q3 2020, up 28% quarter-over-quarter.
- 3 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2020 and 6 closed out, a net change of -3 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2020 was Opaleye Management, an estimated $3.26M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q3 2020 was Dimensional Fund Advisors, an estimated $614K sold.
Based on aggregated 13F filings for Q3 2020.